Emendo Biotherapeutics and Seattle Children’s Research Institute Announce Collaboration to Develop CRISPR-based Therapeutic Strategy for Severe Congenital Neutropenia

ELANE-related SCN, also known as SCN1, is a rare, autosomal [...]

By |2021-12-22T20:50:19+00:00December 22, 2021|3rd Party Medical Device Industry News|Comments Off on Emendo Biotherapeutics and Seattle Children’s Research Institute Announce Collaboration to Develop CRISPR-based Therapeutic Strategy for Severe Congenital Neutropenia
Go to Top